has been cited by the following article(s):
|
[1]
|
Profile of People Living with Human Immunodeficiency Virus Initiating Treatment in the Dolutegravir Era in Kinshasa, Democratic Republic of Congo
|
|
World Journal of …,
2023 |
|
|
|
|
[2]
|
Virological Profile of People Living with HIV after 12 Months of Treatment with Dolutegravir in Kinshasa
|
|
World Journal of …,
2023 |
|
|
|
|
[3]
|
Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa
|
|
Advances in Infectious …,
2023 |
|
|
|
|
[4]
|
Clinical and Anthropometric Evolution of People Living with Human Immunodeficiency Virus during 6 Months of Dolutegravir Treatment in Kinshasa …
|
|
World Journal of …,
2023 |
|
|
|
|
[5]
|
Evolutionary Profile of Opportunistic Infections in People Living with Human Immunodeficiency Virus during Six Months of Dolutegravir Based Antiretroviral …
|
|
World Journal of …,
2023 |
|
|
|
|
[6]
|
PROFIL EPIDEMIOLOGIQUE, CLINIQUE ET THERAPEUTIQUE DES PATIENTS INFECTES PAR LE VIH SOUS TRAITEMENT ANTIRETROVIRAL A …
|
|
Mali Médical,
2023 |
|
|
|
|
[7]
|
Sociodemographic and Anthropometric Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of …
|
|
Open Access Library …,
2022 |
|
|
|
|
[8]
|
Clinical Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of Congo
|
|
Open Access Library …,
2022 |
|
|
|
|
[9]
|
Opportunistic Infections in People Living with Human Immunodeficiency Virus Initiating Antiretroviral Therapy in Kinshasa, Democratic Republic of Congo
|
|
Austin J Infect …,
2022 |
|
|
|
|
[10]
|
Evaluation of the Efficacy of the Phyto-Drug Djovikas: Traditional Treatment against HIV Infection
|
|
ARC Journal of AIDS,
2019 |
|
|
|
|
[11]
|
Evaluation of the Effectiveness of the Cotrimoxazole and Antiretrovirals Association among Adult People Living with HIV: Case of Pilot Health Center and …
|
|
2018 |
|
|
|
|
[1]
|
Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa
Advances in Infectious Diseases,
2023
DOI:10.4236/aid.2023.134054
|
|
|
|